Cargando…
Strong association of glaucoma with atherosclerosis
Carbonic anhydrases (CAs) catalyze the synthesis of HCO(3)(-) from H(2)O and CO(2.) The dysfunction of CAs leads to aqueous humor secretion and high intraocular pressure to cause glaucoma pathogenesis. Methazolamide (MTZ), a CA inhibitor, can effectively treat glaucoma by reducing aqueous humor secr...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8062555/ https://www.ncbi.nlm.nih.gov/pubmed/33888852 http://dx.doi.org/10.1038/s41598-021-88322-4 |
_version_ | 1783681791317508096 |
---|---|
author | Song, Xianqin Li, Peng Li, Yunfeng Yan, Xinfeng Yuan, Lin Zhao, Cong An, Yi Chang, Xiaotian |
author_facet | Song, Xianqin Li, Peng Li, Yunfeng Yan, Xinfeng Yuan, Lin Zhao, Cong An, Yi Chang, Xiaotian |
author_sort | Song, Xianqin |
collection | PubMed |
description | Carbonic anhydrases (CAs) catalyze the synthesis of HCO(3)(-) from H(2)O and CO(2.) The dysfunction of CAs leads to aqueous humor secretion and high intraocular pressure to cause glaucoma pathogenesis. Methazolamide (MTZ), a CA inhibitor, can effectively treat glaucoma by reducing aqueous humor secretion. We previously reported that carbonic anhydrase I (CA1), a CA family member, was highly expressed in atherosclerotic tissues of the aorta and stimulated atherosclerosis (AS) by promoting calcification. MTZ showed therapeutic and preventive effects on AS in a mouse model. The above findings suggest a relationship between AS and glaucoma. This study explored the possible association between AS prevalence and glaucoma prevalence and the therapeutic effect of MTZ on AS by analyzing medical records. Among 10,751 patients with a primary diagnosis of glaucoma, 699 (6.5%) were also diagnosed with AS. However, the incidences of AS in patients with keratitis and scleritis, which are also ophthalmic diseases, were 2.5% (206/8383 patients) and 3.5% (46/1308 patients), respectively. In the population without ophthalmic records, the AS prevalence was only 1.9% (99,416/5,168,481 patients) (all p values between each group were below 0.001). Among 152,425 patients with a primary diagnosis of AS, 1245 (0.82%) were also diagnosed with glaucoma. Among 199,782 patients with a primary diagnosis of hypertension (excluding AS), 1149 (0.57%) were diagnosed with glaucoma, and among 5,313,433 patients without AS or hypertension, 9513 (0.18%) were diagnosed with glaucoma (all p values between each group were below 0.001). Additionally, among 14 patients who suffered from both AS and glaucoma and were treated with MTZ to cure their glaucoma, 9 of them showed reduced low-density lipoprotein (LDL) levels, the main index of AS, within 3 months after medication use (2.81 ± 0.61 mmol/L vs. 2.38 ± 0.58 mmol/L, p = 0.039). The above findings demonstrated a strong relation between AS and glaucoma and suggested that AS patients with glaucoma were more likely to suffer from angle-closure glaucoma. |
format | Online Article Text |
id | pubmed-8062555 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-80625552021-04-23 Strong association of glaucoma with atherosclerosis Song, Xianqin Li, Peng Li, Yunfeng Yan, Xinfeng Yuan, Lin Zhao, Cong An, Yi Chang, Xiaotian Sci Rep Article Carbonic anhydrases (CAs) catalyze the synthesis of HCO(3)(-) from H(2)O and CO(2.) The dysfunction of CAs leads to aqueous humor secretion and high intraocular pressure to cause glaucoma pathogenesis. Methazolamide (MTZ), a CA inhibitor, can effectively treat glaucoma by reducing aqueous humor secretion. We previously reported that carbonic anhydrase I (CA1), a CA family member, was highly expressed in atherosclerotic tissues of the aorta and stimulated atherosclerosis (AS) by promoting calcification. MTZ showed therapeutic and preventive effects on AS in a mouse model. The above findings suggest a relationship between AS and glaucoma. This study explored the possible association between AS prevalence and glaucoma prevalence and the therapeutic effect of MTZ on AS by analyzing medical records. Among 10,751 patients with a primary diagnosis of glaucoma, 699 (6.5%) were also diagnosed with AS. However, the incidences of AS in patients with keratitis and scleritis, which are also ophthalmic diseases, were 2.5% (206/8383 patients) and 3.5% (46/1308 patients), respectively. In the population without ophthalmic records, the AS prevalence was only 1.9% (99,416/5,168,481 patients) (all p values between each group were below 0.001). Among 152,425 patients with a primary diagnosis of AS, 1245 (0.82%) were also diagnosed with glaucoma. Among 199,782 patients with a primary diagnosis of hypertension (excluding AS), 1149 (0.57%) were diagnosed with glaucoma, and among 5,313,433 patients without AS or hypertension, 9513 (0.18%) were diagnosed with glaucoma (all p values between each group were below 0.001). Additionally, among 14 patients who suffered from both AS and glaucoma and were treated with MTZ to cure their glaucoma, 9 of them showed reduced low-density lipoprotein (LDL) levels, the main index of AS, within 3 months after medication use (2.81 ± 0.61 mmol/L vs. 2.38 ± 0.58 mmol/L, p = 0.039). The above findings demonstrated a strong relation between AS and glaucoma and suggested that AS patients with glaucoma were more likely to suffer from angle-closure glaucoma. Nature Publishing Group UK 2021-04-22 /pmc/articles/PMC8062555/ /pubmed/33888852 http://dx.doi.org/10.1038/s41598-021-88322-4 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Song, Xianqin Li, Peng Li, Yunfeng Yan, Xinfeng Yuan, Lin Zhao, Cong An, Yi Chang, Xiaotian Strong association of glaucoma with atherosclerosis |
title | Strong association of glaucoma with atherosclerosis |
title_full | Strong association of glaucoma with atherosclerosis |
title_fullStr | Strong association of glaucoma with atherosclerosis |
title_full_unstemmed | Strong association of glaucoma with atherosclerosis |
title_short | Strong association of glaucoma with atherosclerosis |
title_sort | strong association of glaucoma with atherosclerosis |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8062555/ https://www.ncbi.nlm.nih.gov/pubmed/33888852 http://dx.doi.org/10.1038/s41598-021-88322-4 |
work_keys_str_mv | AT songxianqin strongassociationofglaucomawithatherosclerosis AT lipeng strongassociationofglaucomawithatherosclerosis AT liyunfeng strongassociationofglaucomawithatherosclerosis AT yanxinfeng strongassociationofglaucomawithatherosclerosis AT yuanlin strongassociationofglaucomawithatherosclerosis AT zhaocong strongassociationofglaucomawithatherosclerosis AT anyi strongassociationofglaucomawithatherosclerosis AT changxiaotian strongassociationofglaucomawithatherosclerosis |